Literature DB >> 8412003

Functional studies in fibroblasts of adenylosuccinase-deficient children.

F Van den Bergh1, M F Vincent, J Jaeken, G Van den Berghe.   

Abstract

In fibroblasts of severely retarded (type I) adenylosuccinase (ASase)-deficient children, activities with the two substrates of the enzyme, succinylaminoimidazole carboxamide ribotide (succinyl-AICAR) and adenylosuccinate are decreased in parallel, to about 30% of normal. In a markedly less retarded (type II) patient, ASase activity with adenylosuccinate reaches only 3% of normal, whereas activity with succinyl-AICAR is also about 30% of normal. To assess the functional significance of a partial versus a profound deficiency of ASase, precursor incorporation studies were performed in intact fibroblasts. In cells from controls and from type I patients, incorporation of 0.2 mmol/L [14C]formate into adenine and guanine nucleotides was not accompanied by accumulation of either [14C]succinyl-AICAR or [14C]adenylosuccinate. Similarly, incorporation of 20 mumol/L [14C]hypoxanthine was not accompanied by accumulation of [14C]adenylosuccinate. In contrast, in fibroblasts of the type II patient, in accordance with the profound deficiency of ASase with adenylosuccinate, and with the inhibitory effect of Cl- and nucleotides on the activity with succinyl-AICAR, incorporation of [14C]formate resulted in accumulation of [14C]succinyl-AICAR and [14C]adenylosuccinate, and incorporation of [14C]hypoxanthine in a marked build-up of [14C]adenylosuccinate. That both precursors were still incorporated into the adenine nucleotides of the fibroblasts of the type II patient indicates that adenylate synthesis remains possible even with 3% residual ASase activity, as also shown by their grossly normal ATP concentrations. The results suggest that the pathophysiology of ASase deficiency may be mediated at least in part by accumulation of succinyladenosine and succinyl-AICAriboside.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8412003     DOI: 10.1007/bf00710293

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

1.  The performance of microparticle chemically-bonded anion-exchange resins in the analysis of nucleotides.

Authors:  R A Hartwick; P R Brown
Journal:  J Chromatogr       Date:  1975-10-29

2.  Regulation of de novo purine synthesis in human lymphoblasts. Similar rates of de novo synthesis during growth by normal cells and mutants deficient in hypoxanthine-guanine phosphoribosyltransferase activity.

Authors:  M S Hershfield; J E Seegmiller
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

3.  Adenylosuccinase deficiency.

Authors:  G Van den Berghe; J Jaeken
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

4.  Regulation of purine nucleotide synthesis. Effects of inosine on normal and hypoxantine-guanine phosphoribosyltransferase-deficient fibroblasts.

Authors:  M A Becker
Journal:  Biochim Biophys Acta       Date:  1976-06-18

5.  Repression and derepression of purine biosynthesis in mammalian hepatoma cells in culture.

Authors:  D W Martin; N T Owen
Journal:  J Biol Chem       Date:  1972-09-10       Impact factor: 5.157

6.  Purine biosynthesis in Chinese hamster cell mutants and human fibroblasts partially deficient in adenylosuccinate lyase.

Authors:  P K Laikind; H E Gruber; I Jansen; L Miller; M Hoffer; J E Seegmiller; R C Willis; J Jaeken; G Van den Berghe
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

7.  An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids.

Authors:  J Jaeken; G Van den Berghe
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

8.  Residual adenylosuccinase activities in fibroblasts of adenylosuccinase-deficient children: parallel deficiency with adenylosuccinate and succinyl-AICAR in profoundly retarded patients and non-parallel deficiency in a mildly retarded girl.

Authors:  F Van den Bergh; M F Vincent; J Jaeken; G Van den Berghe
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

9.  Adenylosuccinase deficiency: an inborn error of purine nucleotide synthesis.

Authors:  J Jaeken; S K Wadman; M Duran; F J van Sprang; F A Beemer; R A Holl; P M Theunissen; P de Cock; F van den Bergh; M F Vincent
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183

  9 in total
  6 in total

1.  Structural and biochemical characterization of human adenylosuccinate lyase (ADSL) and the R303C ADSL deficiency-associated mutation.

Authors:  Stephen P Ray; Michelle K Deaton; Glenn C Capodagli; Lauren A F Calkins; Lucas Sawle; Kingshuk Ghosh; David Patterson; Scott D Pegan
Journal:  Biochemistry       Date:  2012-08-07       Impact factor: 3.162

Review 2.  Inborn errors of the purine nucleotide cycle: adenylosuccinase deficiency.

Authors:  G Van den Berghe; M F Vincent; J Jaeken
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

3.  Molecular characterization of the AdeI mutant of Chinese hamster ovary cells: a cellular model of adenylosuccinate lyase deficiency.

Authors:  Lydia K Vliet; Terry G Wilkinson; Nathan Duval; Guido Vacano; Christine Graham; Marie Zikánová; Vaclava Skopova; Veronika Baresova; Aleš Hnízda; Stanislav Kmoch; David Patterson
Journal:  Mol Genet Metab       Date:  2010-09-06       Impact factor: 4.797

4.  Analysis of abnormalities in purine metabolism leading to gout and to neurological dysfunctions in man.

Authors:  R Curto; E O Voit; M Cascante
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

Review 5.  Adenylosuccinate lyase deficiency.

Authors:  Agnieszka Jurecka; Marie Zikanova; Stanislav Kmoch; Anna Tylki-Szymańska
Journal:  J Inherit Metab Dis       Date:  2014-08-12       Impact factor: 4.982

6.  Clinical and molecular characterization of patients with adenylosuccinate lyase deficiency.

Authors:  Gerarda Mastrogiorgio; Marina Macchiaiolo; Paola Sabrina Buonuomo; Emanuele Bellacchio; Matteo Bordi; Davide Vecchio; Kari Payne Brown; Natalie Karen Watson; Benedetta Contardi; Francesco Cecconi; Marco Tartaglia; Andrea Bartuli
Journal:  Orphanet J Rare Dis       Date:  2021-03-01       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.